Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

SWIR Otoscopy Study

NCT: NCT06944795 · RECRUITING

NCT IDNCT06944795
StatusRECRUITING
Start Date2026-04-30
Completion2027-07
SponsorStanford University (OTHER)
First posted
Last updated

Brief Summary

The aim of this study is to provide preliminary data to support future studies to demonstrate that the short wave infrared (SWIR) otoscope is a better diagnostic tool than a white light otoscope for diagnosing middle ear infections (otitis media). Patients who are having a tympanostomy tube placement procedure will be participating in this study. Imaging will be performed with the white light otoscope and the SWIR otoscope to determine presence of absence of fluid. The SWIR otoscope will gather SWIR data and white light data simultaneously. As part of standard of care, patients who come in for this procedure have removal of middle ear fluid as part of their procedure, which will confirm presence or absence of fluid.

Frequently Asked Questions

What is SWIR Otoscopy Study?

SWIR Otoscopy Study is a clinical trial registered under NCT06944795. Current status: RECRUITING.

What is the status of NCT06944795?

The current status of NCT06944795 (SWIR Otoscopy Study) is: RECRUITING.

When did SWIR Otoscopy Study start?

SWIR Otoscopy Study started on 2026-04-30.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.